VEGFA and lung cancer: Bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor A (VEGFA) and an anti‐angiogenic treatment, is an effective treatment for several malignant tumors including colorectal, ovarian, and non‐small cell lung cancer [9, 10, 11].